Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded a new revision entry for v3.4.3 and removed the v3.4.2 entry from the version history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.4.2 to the history. Removed the government-funding notice and the v3.4.1 entry from the history.SummaryDifference0.7%

- Check44 days agoChange DetectedAdded a notice about a lapse in government funding and the NIH Clinical Center’s operating status with links to cc.nih.gov and opm.gov. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check51 days agoChange DetectedThe history page now includes a glossary display option and uses green highlights for additions and red highlights for deletions to visualize changes, and retains the No FEAR Act Data section; the revision tag has been updated to Revision: v3.4.0.SummaryDifference1.0%

- Check65 days agoChange DetectedA new revision entry v3.3.4 is added to the record history, while the previous v3.3.3 entry remains visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.